The site in Sichuan province will help the country deal with growing quantities of radioactive material as it steps up its use of nuclear power.
Japanese astronaut Aki Hoshide of JAXA and French astronaut Thomas Pesquet of ESA installed the mount for a solar array outside of the International Space Station during the first spacewalk to not include an American or Russian crew member.
Some thoughts about possible communication with intelligent alliens, for more info see:
Contact with intelligent aliens would happen on their terms, not ours.
Longer, Healthier, And More Productive Lives — Dr. Jean Accius Ph.D., Senior Vice President, AARP
Dr. Jean C. Accius, PhD, is Senior Vice President, AARP Global Thought Leadership (https://www.aarp.org/). Dr. Accius leads a team in positioning AARP (formerly known as the American Association of Retired Persons) as a global thought leader, identifying emerging trends around the world, cultivating and elevating new ideas, forging global strategic alliances that become the foundation for collaboration and sparking bold solutions to change systems and improve the lives of the global population as it ages.
Anna’s guest at Women’s Radio was Dr Ian C E Hale I’m an Autistic person. It’s an indivisible part of who I am as an individual.
Annas guest at Women’s Radio was Dr Ian C E Hale ‘All things Autism will be aired at 1pm and 1am every day this week. Please see www.womensradiostation.com
The NHS has launched the world’s largest trial of a potentially gamechanging blood test that aims to detect more than 50 types of cancer before symptoms appear.
More than 100,000 volunteers are being sought to provide blood samples at mobile test clinics in regions across England from Monday to assess how well the test works in the health service.
BioNTech, the company that partnered with Pfizer to develop a COVID-19 vaccine, is now testing whether mRNA can be used to treat cancer.
Messenger RNA (mRNA) vaccines work by tricking our bodies into producing a small part of a virus. For the Pfizer–BioNTech COVID-19 vaccine, this involved isolating the spike protein of SARS-CoV-2 (the virus that causes COVID-19). This protrudes from the outer surface of the virus and is used to latch onto specific cells in your body, infecting them and causing more copies of the virus to be made. Researchers obtained the spike protein’s RNA, then created mRNA based on these molecular instructions.
Once injected, the mRNA vaccine will instruct cells to build spike proteins in large volumes – not the virus itself, just the spike protein. This is enough to kickstart our immune response, training the body to recognise the spike protein, without making us sick. B-cells (also known as lymphocytes) can last for months or years and will “remember” the spike protein, making Y-shaped proteins called antibodies to destroy any SARS-CoV-2 encountered in the future.
Mysterious effects in a new generation of dark matter detectors could herald a revolutionary discovery.
Tesla may already have a lot of projects on its plate, but the company still appears to be exploring other projects for its product lineup in the future. Among these is a “Robo Van” that’s optimized to transport people with disabilities, among others.
References to the Tesla “Robo Van” were reportedly shared by CEO Elon Musk during the company’s recent all-hands meeting, according to individuals familiar with the topics covered in the event. Apart from the “Robo Van” being capable of transporting large numbers of people, Musk reportedly highlighted that the upcoming vehicle would be designed to address the needs of passengers with disabilities.
This suggests that the Tesla “Robo Van” would be optimized for easy ingress and egress, making it perfect for passengers who may have difficulty getting into conventional vehicles. Features such as active air suspension, similar to the one used in the Cybertruck, would be particularly useful for disabled passengers as well, as they would make it easier for items such as wheelchairs to be loaded and unloaded from the Tesla “Robo Van.”
While is seems like the majority of the longevity space is currently overly captivated by the Aubrey de Grey/SENS debacle, the U.S. National Academy of Sciences, Healthy Longevity Global Innovator Summit is now beginning — Most interestingly, former R&D Head at PepsiCo, Dr. Mehmoud Khan, will be speaking in his new role as CEO of the Hevolution Foundation; a potential multi-billion $$$ initiative with a longevity angle — Everyone should keep their eye on this one…
The National Academy of Medicine (NAM) will hold its inaugural Healthy Longevity Global Innovator Summit in September 2,021 with support from Johnson and Johnson Innovation and The John A. Hartford Foundation. The event will be virtual and held over three days, September 13 14, and 22 and feature an immersive, interactive digital venue with unique opportunities to engage and connect.
The Innovator Summit will honor the 154 international Healthy Longevity Catalyst Awardees from 2020 and bring together industry leaders, academics, researchers, scientists, and entrepreneurs whose work contributes to the field of healthy longevity. Attendees will learn about the early-stage, award-winning innovations, hear from leaders in the field of healthy longevity, and take advantage of various opportunities to interact directly with other attendees, with a view to fostering interdisciplinary and cross-sector collaboration.
Continue reading “Healthy Longevity Global Innovator Summit” »
